Berenberg analyst Victoria Lambert raised the firm’s price target on Fresenius Medical (FMS) to EUR 55 from EUR 47 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical price target raised to $25 from $23 at Truist
- Fresenius Medical Care Rejoins DAX 40, Signifying Strategic Success
- Fresenius Medical Care Announces Release of Bond Guarantee
- Cara Therapeutics, Tvardi Therapeutics enter definitive merger agreement
- Fresenius Medical Care Resolves Legal Proceedings on Company Restructuring